Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bayer
Related studies linked through entity extraction aliases.
The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL
- Status
- TERMINATED
- Phase
- PHASE2
The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP
- Status
- COMPLETED
- Phase
- PHASE2
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study
- Status
- COMPLETED
- Phase
- PHASE3
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study
- Status
- COMPLETED
- Phase
- PHASE3
Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Study of Knowledge Translation of Clinical Practice Guidelines for Ventilator Associated Pneumonia
- Status
- COMPLETED
- Phase
- N/A
Investigation of Mass Balance of the Test Drug and Major Metabolites
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia
- Status
- COMPLETED
- Phase
- PHASE3
Herceptin and GM-CSF for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension
- Status
- COMPLETED
- Phase
- PHASE2
Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
- Status
- COMPLETED
- Phase
- PHASE4
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
BATTLE Program: Sorafenib in Patients With NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face
- Status
- COMPLETED
- Phase
- PHASE2